Back to Lymphangioleiomyomatosis

Research record changes

The latest 100 trial status and retraction changes detected since change tracking began. Dates show when RareWays recorded the change, which may be later than the source update. Earlier history is unavailable.

  1. A National Registry on Chinese Patients With Lymphangioleiomyomatosis

    RECRUITING → UNKNOWN

    Recorded 2026-10-02

    View record
  2. Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

    ACTIVE NOT RECRUITING → TERMINATED

    Recorded 2026-10-01

    View record
  3. [Retracted] A Systematic Review of Lymphangioleiomyomatosis on Diagnosis and Molecular Mechanism

    Retraction flag: retracted

    Recorded 2026-10-01

    View record